Services

Header

Header

Header

SUMOylated Peptides

Custom site-specific SUMOylated peptide synthesis using solid-phase peptide synthesis (SPPS), orthogonal lysine protection, chemoselective ligation, and advanced analytical characterization.

SUMO-1 SUMO-2 SUMO-3 Isopeptide Linkage Custom Conjugates

Defined SUMO Chemistry for Site-Specific Peptide Research

SUMOylation is a reversible post-translational modification in which a small ubiquitin-like modifier (SUMO) is attached through its C-terminal glycine to the ε-amino group of a selected lysine residue. In cells, the reaction is coordinated by the SAE1/SAE2 activating enzyme, the UBC9 conjugating enzyme, and SUMO E3 ligases.

SUMOylation can influence protein localization, transcription, chromatin organization, DNA-damage responses, stress signaling, and protein-protein interactions. Chemically defined SUMOylated peptides provide controlled materials for mechanistic studies, binding assays, antibody evaluation, and analytical method development.

Many SUMOylation events occur within the consensus motif ΨKxE (where Ψ represents a hydrophobic residue, K is the modified lysine, x is any amino acid, and E is glutamic acid), although important non-consensus SUMOylation sites have also been identified.

Bio-Synthesis develops project-specific routes using Fmoc-based SPPS, orthogonal lysine protection, segment ligation, and chemoselective conjugation. Full SUMO conjugates, motif peptides, linkage mimics, and analytical standards are evaluated individually for sequence, topology, scale, purification, and release testing.

Biological Function

Supports studies of protein localization, transcription, DNA repair, chromatin organization, and cellular stress responses.

Synthetic Chemistry

Uses SPPS, orthogonal lysine protection, and chemoselective ligation to create site-defined SUMO constructs.

Research Applications

Provides defined materials for enzyme assays, binding studies, proteomics, biomarker work, and therapeutic research.

Native Lysine SUMOylation

SUMO C-terminal glycine linked to a target lysine side chain.

SUMO-1 / 2 / 3C-terminal glycineGIsopeptide BondSUMO–Gly–CO–NH–LysTarget Peptide Lysineε-amino group at a defined site
Modification SUMOylation
Target residue Lysine
Linkage Isopeptide bond
Cellular E2 UBC9
Common isoforms SUMO-1, SUMO-2, SUMO-3
Synthetic routes SPPS · Ligation · Conjugation

Design note: SUMOylated constructs can vary substantially in size and topology. Sequence, isoform, attachment site, native-versus-mimic linkage, and analytical endpoint should be defined before route development.

Two Routes to a Defined SUMO Signal

Cellular SUMOylation is enzyme-driven and reversible. Chemical synthesis provides a controlled material with a defined sequence, attachment site, and linkage architecture.

Cellular SUMOylation

Biological installation and removal in the cell.

Maturation SENP proteases expose the C-terminal diglycine motif.
Activation ATP-dependent SAE1/SAE2 activates SUMO.
Transfer UBC9 carries activated SUMO.
Specificity E3 ligases and substrate context influence conjugation.
Dynamics SENPs can remove or remodel SUMO signals.

Custom Chemical Synthesis

Defined route design for standards and mechanistic studies.

Assembly SPPS builds the target peptide and synthetic segments.
Site Control Orthogonal protection exposes a selected lysine.
Connection Native or engineered chemoselective ligation strategy.
Outcome Defined motif peptide, conjugate, mimic, or analytical standard.
Reproducibility Consistent site, composition, and reference material.

Route Selection Is Matched to SUMO Construct Complexity

Depending on the peptide sequence, modification site, and project objectives, Bio-Synthesis develops customized synthetic strategies that may incorporate solid-phase peptide synthesis (SPPS), orthogonal protecting group chemistry, native chemical ligation (NCL), chemoselective ligation, or post-synthetic conjugation.

Orthogonal SPPS

Fmoc-based SPPS builds the target peptide while orthogonal lysine protection preserves one ε-amino group for selective SUMO attachment.

  • Consensus-motif peptides
  • Short SUMO mimics
  • Multi-modified standards

Chemical Ligation

Peptide segments may be joined through native chemical ligation or related thiol-mediated approaches, followed when appropriate by desulfurization.

  • Longer synthetic constructs
  • Native backbone assembly
  • Segment-based route design

Isopeptide-Bond Formation

Project-specific auxiliaries, activated C termini, or chemoselective handles can connect SUMO-derived material to the selected lysine side chain.

  • SUMO conjugates
  • Native or linkage-mimic designs
  • Custom architecture development

Purification & Verification

Preparative purification and analytical testing are designed around molecular size, hydrophobicity, linkage stability, and intended use.

  • Analytical HPLC
  • LC-MS or HRMS
  • Optional MS/MS mapping

Choose the Construct That Matches the Research Question

“SUMOylated peptide” can refer to motif peptides, full SUMO conjugates, linkage mimics, analytical standards, or custom multi-modified constructs. Defining the required format early helps align route design and release testing.

01

SUMO-1 Modified Peptides

Site-defined SUMO-1 constructs or SUMO-1-derived mimics for regulatory, localization, and binding studies.

SUMO-1 Biology
02

SUMO-2 Modified Peptides

SUMO-2-related conjugates, motifs, or analytical constructs for stress-response and chain-formation studies.

SUMO-2 Signaling
03

SUMO-3 Modified Peptides

SUMO-3-related constructs for isoform comparison, proteomics, and mechanism-focused assay development.

SUMO-3 Research
04

Consensus-Motif Peptides

Peptides containing defined ΨKxE-type or non-consensus sites for UBC9, ligase, SENP, antibody, or reader studies.

Enzyme & Binding Assays
05

Stable Isotope Standards

Heavy amino-acid incorporation into SUMO-related peptide standards for targeted quantitative mass spectrometry.

Quantitative LC-MS
06

Custom SUMO Conjugates

Feasibility-driven designs combining SUMOylation with labels, handles, affinity tags, or selected additional PTMs.

Custom Route Design

SUMO-1, SUMO-2, and SUMO-3 Support Distinct but Overlapping Biology

SUMO-1 is more sequence-divergent, while mature SUMO-2 and SUMO-3 are highly similar. Isoform selection should follow the biological question, literature precedent, target protein, assay format, and analytical method.

SUMO-1

Often associated with stable monomeric modification and distinct substrate preferences.

SUMO-2

Closely related to SUMO-3 and frequently studied in stress-responsive SUMOylation.

SUMO-3

Highly similar to SUMO-2; useful for isoform-specific comparison when experimentally distinguishable.

Consensus Motif

Many sites occur in a ΨKxE-like context, although non-consensus SUMOylation is also common.

Poly-SUMO Design

SUMO-2/3 can support chain formation; synthetic chain constructs require project-specific feasibility review.

SENP Substrates

Defined conjugates and mimics can support deSUMOylation, recognition, and inhibitor studies.

Extend SUMOylated Peptides with Complementary Chemistry

Explore modification and analytical capabilities that may be incorporated into SUMO-related peptide designs when the complete protecting-group, ligation, purification, and characterization strategy remains compatible.

Compatibility review: combining SUMOylation with other modifications can significantly affect route design, orthogonal protection, ligation order, solubility, purification, and analytical interpretation. Final feasibility is confirmed after sequence and construct review.

Planning a multi-modified construct? Our scientists evaluate sequence compatibility, modification order, synthetic feasibility, purification strategy, and analytical requirements before synthesis.

Defined Peptide Tools for SUMO Biology and Proteomics

Construct format should be selected according to whether the study requires a site-specific analytical standard, an enzyme substrate, a binding probe, or a larger SUMO conjugate.

SUMO

SUMO Biology

Study site-specific SUMO recognition, conjugation, and regulatory signaling.

MS

SUMO Proteomics

Develop defined standards and controls for SUMO-site assignment and targeted quantification.

SENP

DeSUMOylase Assays

Prepare defined substrates and probes for SENP recognition, cleavage, and inhibitor studies.

E3

SUMO Ligase Research

Support substrate-recognition, ligase-specificity, and inhibitor-screening studies.

CHR

Chromatin Regulation

Investigate SUMO-dependent protein interactions in chromatin and transcriptional control.

DDR

DNA Damage Response

Model selected SUMO signals involved in repair and genome-stability pathways.

NUC

Nuclear Transport

Examine SUMO-dependent localization, transport, and nuclear-protein interactions.

DD

Drug Discovery

Prepare assay materials for SUMO enzymes, SENPs, readers, and pathway-focused screening.

Define the Chemical Question Before Synthesis

SUMOylated peptide projects become substantially more predictable when site, linkage, topology, scale, and analytical use are specified at the beginning.

Construct Type

Confirm whether the project requires a consensus-motif peptide, full SUMO conjugate, SUMO fragment, chain construct, or synthetic linkage mimic.

Attachment Site

Identify the modified lysine, SUMO isoform, and residue numbering based on the full protein or submitted peptide sequence.

Linkage Requirement

Specify native isopeptide linkage, SUMO isoform, mono- or poly-SUMO architecture, linkage mimic, or method-development construct.

Additional Modifications

List isotope labels, affinity tags, fluorophores, other PTMs, reactive handles, and terminal modifications.

Solubility & Purification

SUMO-containing constructs can show complex folding, solubility limits, and co-eluting impurities that affect recovery.

Analytical Endpoint

Define whether release requires routine identity and purity, high-resolution MS, MS/MS mapping, or application-specific testing.

From Feasibility Review to Analytical Release

Route design, synthesis, conjugation, purification, and testing are planned as one integrated process because each stage influences the final construct.

1
Project Review

Sequence, site, linkage, scale, and intended use

2
Route Design

SPPS, orthogonal protection, ligation, and QC plan

3
Segment Synthesis

Target peptide and required ubiquitin-derived components

4
Conjugation

Site-selective isopeptide or fit-for-purpose linkage formation

5
Purification

Preparative method matched to molecular complexity

6
QC & Release

Identity, purity, and project-specific characterization

Discuss Your SUMOylated Peptide Project

Share your peptide sequence, preferred SUMO isoform, modification site or sites, additional PTMs, purity requirements, and analytical needs. Our peptide scientists will review the design and recommend an appropriate synthetic, purification, and characterization strategy.

Before You Submit Your Project

  • Target peptide sequence and residue numbering
  • Modified lysine site or SUMO linkage position
  • SUMO-1, SUMO-2, SUMO-3, motif peptide, conjugate, or mimic design
  • Native linkage requirement versus acceptable analog
  • Additional PTMs, labels, tags, or reactive handles
  • Required quantity, purity, and formulation
  • Planned assay, LC-MS method, or biological use

How We Evaluate Your Design

We review sequence complexity, protecting-group strategy, segment length, ligation chemistry, linkage stability, solubility, purification risk, analytical detectability, and scale. When the requested route is impractical, we explain the limitation and propose a scientifically appropriate alternative.

Integrated Support from Research Scale to Manufacturing

Project controls are selected according to construct complexity, intended use, scale, and release requirements.

Scientific & Sequence Review

Feasibility assessment covering site, linkage, route, solubility, and analytical strategy before synthesis begins.

Controlled Synthesis

Documented SPPS, protection, ligation, conjugation, and purification strategy matched to the construct.

Analytical Confirmation

Identity and purity assessed by methods such as analytical HPLC, LC-MS, HRMS, or optional MS/MS.

Documentation & Scale-Up

Project-specific release documentation with pathways for research, pilot, and larger-scale manufacturing support.

ISO 9001:2015 ISO 13485:2016 GLP Support ISO 14001 Preparative HPLC Mass Spectrometry Optional Amino Acid Analysis GMP-Aligned Support

SUMOylated Peptides FAQ

FAQ

What is a SUMOylated peptide?
A SUMOylated peptide contains a SUMO-derived modification attached at a defined peptide site, usually through an isopeptide bond between the SUMO C terminus and a lysine ε-amino group.
Is SUMOylation the same as ubiquitination?
No. Both use ubiquitin-like protein modifiers and lysine isopeptide bonds, but they use different modifiers, enzymes, recognition systems, and biological outcomes.
How are SUMOylated peptides synthesized?
Routes may combine Fmoc-based SPPS, orthogonal lysine protection, segment ligation, chemoselective conjugation, preparative purification, and analytical characterization.
What is the difference between SUMO-1, SUMO-2, and SUMO-3?
SUMO-1 is more sequence-divergent, while mature SUMO-2 and SUMO-3 are highly similar. The appropriate isoform depends on the target, pathway, assay, and literature precedent.
Can you prepare native isopeptide linkages?
Native or near-native linkage strategies may be possible depending on sequence, construct size, attachment site, topology, and scale. Each project requires feasibility review.
Can SUMO consensus-motif peptides be synthesized?
Yes. Peptides containing ΨKxE-type or non-consensus SUMOylation sites can be prepared for enzyme, binding, antibody, and analytical studies.
Can SUMOylated peptides contain stable isotope labels?
Yes. Heavy amino acids can be incorporated into SUMO-related peptide standards for targeted quantitative LC-MS applications.
Can SUMOylation be combined with other PTMs?
Selected combinations with phosphorylation, acetylation, methylation, citrullination, glycosylation, labels, affinity tags, or click handles may be possible when the full synthetic route is compatible.
How are SUMOylated peptides characterized?
Typical testing may include analytical HPLC and mass spectrometry. High-resolution MS, MS/MS mapping, amino acid analysis, or other project-specific methods can be considered.
What information is needed for a quotation?
Provide the target sequence, residue numbering, modified lysine, SUMO isoform, desired construct format, quantity, purity, formulation, additional modifications, and intended application.

Recommended Reading

Selected literature supporting SUMO conjugation, UBC9-mediated site selection, SUMO isoform biology, SUMO proteomics, and cellular regulation discussed on this page.

  1. Johnson ES. Protein modification by SUMO. Annual Review of Biochemistry. 2004;73:355–382.
  2. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nature Reviews Molecular Cell Biology. 2007;8:947–956.
  3. Flotho A, Melchior F. Sumoylation: a regulatory protein modification in health and disease. Annual Review of Biochemistry. 2013;82:357–385.
  4. Hendriks IA, Vertegaal ACO. A comprehensive compilation of SUMO proteomics. Nature Reviews Molecular Cell Biology. 2016;17:581–595.
  5. Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD. Structural basis for E2-mediated SUMO conjugation revealed by a complex between UBC9 and RanGAP1. Cell. 2002;108:345–356.
  6. Pichler A, Fatouros C, Lee H, Eisenhardt N. SUMO conjugation — a mechanistic view. Biomolecular Concepts. 2017;8:13–36.

Scientific note: SUMOylation is often context-dependent and can occur at consensus or non-consensus lysines. Isoform choice, neighboring sequence, accessibility, chain formation, and deSUMOylation can all affect biological interpretation; synthetic constructs should therefore be designed around a defined experimental question.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.